Efficacy and safety of ASF-1096 Cream 0.5% in the treatment of patients with newly developed discoid lupus erythematosus (DLE) lesions. A multicentre clinical phase 2, placebo controlled and double blind proof of concept study.
Phase of Trial: Phase II
Latest Information Update: 02 Jun 2011
At a glance
- Drugs Levosalbutamol (Primary)
- Indications Discoid lupus erythematosus; Systemic lupus erythematosus
- Focus Therapeutic Use
- 02 Jun 2011 New trial record